As part of its annual Industry Issues Conference in December, Drug Store News hosted the Chronic Care and Retail Health Roundtable, expanding the program for the first time in its 15 year-existence beyond the diabetes management.
Camber has launched its generic of Pfizer’s high blood pressure and chest pain treatment Corgard.
Fred's Super Dollar's comparable store sales for January rose 0.7% on top of an increase of 4.3% in the year-earlier period.
Clinicians can better estimate the risk of glaucoma progression by looking at a readout from the smart lens. The findings could also have implications when using the lenses to evaluate glaucoma treatments.
The agreement enables Publix’s network of more than 980 pharmacy locations across the southeast to expand patient access to specialty medications.
The company, alongside the launch of the drug, is offering a savings program for patients, which it said would reduce co-payments to $10 for the drug.
The asthma treatment is a once-daily dose of two 1.25-microgram puffs.
Reuters is reporting that in 2016, there will likely be seven blockbuster drugs launched, each of which has potential to see more than $1 billion in annual sales. The ones that are poised to be the biggest are a chronic liver desease drug from Intercept Pharmaceuticals and Gilead’s fixed-dose treatment for H.I.V, which experts forecast could make $2.6 billion and $2 billion, respectively. (Reuters)